India Glycols Ltd

Q4 FY26Beverages

India Glycols Ltd Q4 FY26 Results & Concall Highlights: Revenue, Margins & Order Book

Q4 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹1,146

Market cap₹7.1K Cr

P/E22.4

Updated23 Aug 2026

Read4 min read

The short version

Chemicals segment expected to see good growth driven by performance chemicals and new products like bio-based amines and dibasic esters. Chemicals business: Cautiously optimistic with expected improved profitability and top-line growth; performance chemicals segment growing strongly with potential for doubling revenue this year and sustained momentum.

From India Glycols Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

Chemicals segment expected to see good growth driven by performance chemicals and new products like bio-based amines and dibasic esters.
Potable Spirits revenue growing, driven by premiumization in IMFL and new product launches (e.g., Bunty Vodka 122% growth, Bunty Jamun).
Bio-Fuels segment shows strong growth with 40.9% increase in FY26 revenue; potential for further growth if ethanol blending targets rise beyond 20% and flexi-fuel vehicles expand.
Ennature Biopharma targeting volume growth via new customer additions, clinical-backed nutraceutical launches, and planned entry into the U.S. market.
Capex focused on expanding two grain distilleries (Gorakhpur and Kashipur) supports future production capacity.
Ongoing efforts to improve Chemicals business quality and expand product portfolio expected to sustain growth.
Premiumization strategy in Potable Spirits likely to increase revenue share from IMFL and improve margins.
Bio-Fuels expected to benefit from government policy support and stable input costs, supporting volume and profit growth.

Profitability & Margins

Chemicals business: Cautiously optimistic with expected improved profitability and top-line growth; performance chemicals segment growing strongly with potential for doubling revenue this year and sustained momentum.
Bio-Fuels: Strong growth driven by 20% ethanol blending policy, with possible future increases beyond 20%; profitability expected to remain healthy due to stable grain prices and policy support.
Ennature Biopharma: Profitability under pressure but expected to improve due to diversification into branded nutraceuticals, clinical studies, and expansion into US markets.
Potable Spirits: Margins maintained around 22%; growth driven by premiumization and new product launches in key regions.
Overall EBITDA margin improved to 15.5% in FY26, with 24.5% EBITDA growth and 26.8% PAT growth, indicating strong earnings momentum going forward.
Debt reduction and cost control measures leading to better interest coverage and financial health, supporting future profit growth.

See what India Glycols Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

INR 830 crores capital expenditure done in the year, with about INR 400 crores invested in two main grain distilleries located at Gorakhpur and Kashipur.
Additional smaller capex projects completed besides the distilleries.
Future debt repayments planned: INR 268 crores liability for FY27, with ongoing efforts to reduce debt further based on cash flow.
Scheme of arrangement for demerger expected to have NCLT hearing by May 21, 2026, with anticipated order in early June, paving way for restructuring and potential strategic moves thereafter.
Continued investments in Ennature Biopharma segment focusing on manufacturing capabilities and customer acquisition for growth and profitability enhancement.
Ongoing strategic shift towards premiumization in Potable Spirit segment with focus on launching more premium brands for future revenue increase.

Top-ranked in Beverages

Ranked on what management guided this quarter

5x potential

1Varun Beverages₹1.4L Cr

Rev 2Mar 3

2Fratelli Vineyards Ltd₹565 Cr

Rev 2Mar 3

3₹17.7K Cr

Rev 3Mar 1

4₹12.9K Cr

Rev 3Mar 1

5₹33.2K Cr

Rev 3Mar 3

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

The company prepaid around INR804 crores in the recent quarter, partly funded by INR467 crores through an equity issue in November 2025 and the rest from cash flow.
There is a liability of INR268 crores due in FY '26-'27, planned to be paid off.
The company is in the process of reducing debt further and targeting prepayments based on cash flow but has not committed to a fixed repayment amount.
Plans for raising capital through debt or equity beyond this are not explicitly mentioned, indicating no immediate new fundraising is announced.
Management aims to achieve a debt-free status for the Chemical business by FY '28-'29 using proceeds from partial equity sale of the JV.
Interest costs are expected to remain at around INR25 crores per quarter, suggesting stable financing costs without significant new borrowings.

See what India Glycols Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The transcript provided from India Glycols Limited's Q4 & FY26 earnings call does not specifically mention details about the current or expected order book or pending orders. Key focuses instead were on: - Capital expenditure mainly in two grain distilleries (Gorakhpur and Kashipur). - Debt repayment and reduction plans. - Business segment performances including Chemicals, Potable Spirits, Bio-Fuels, and Ennature Biopharma. - Shifts towards premiumization in the Potable Spirits segment. - Updates on JV performance and monetization timelines. - Impact of plant shutdowns on production and sales. Therefore, there is no explicit information available about the current or expected order book or pending orders in this document.

India Glycols Ltd — Quarterly revenue & net profit

Revenue Net profit

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹976 Cr, net profit ₹87 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What India Glycols Ltd's management said in earlier quarters

Others in Beverages this season

Piccadily Agro Industries Ltd (Q4 FY26)
IMFL segment driving majority of growth, with 63% quarterly and ~31% annualized growth currently. Key concall takeaways from Piccadily Agro's Q4 FY26 earnings…
BCL Industries Ltd (Q4 FY26)
Current net debt as of March '26 stands around INR 300-335 crores, with interest cost under 7%, including INR 120 crores at subsidized rates. Key concall…
Radico Khaitan (Q4 FY26)
Total IMFL volume in Q4 FY26 grew by **4% year-on-year**. Key concall takeaways from Radico Khaitan's Q4 FY26 earnings call — and how it ranks against sector…
Globus Spirits Ltd (Q4 FY26)
Bulk alcohol (ENA) business exit FY26 volume: approximately 199.5 million liters, around INR 20 crores in value. Key concall takeaways from Globus Spirits…

Compare:vs Varun Beverages Ltd vs Radico Khaitan vs United Breweries Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were India Glycols Ltd Q4 FY26 results?

What is India Glycols Ltd share price analysis?

India Glycols Ltd currently shows a neutral. The stock trades at a P/E of 22.4 with a market cap of ₹7,112 Cr. Investors should review the full earnings analysis for detailed insights.

Is India Glycols Ltd planning capital expenditure?

INR 830 crores capital expenditure done in the year, with about INR 400 crores invested in two main grain distilleries located at Gorakhpur and Kashipur.

Keep India Glycols Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.